1-(2-((1-(4-amino-3-chlorophenyl)methanoyl)amino)-3,3-dimethylbutanoyl)pyrrolidine-2-carboxylic acid,
VX 765,
VX-765,
VX765 cpd,
VX-765,
273404-37-8,
BELNACASAN,
Belnacasan (VX-765),
VX765,
UNII-00OLE78529,
Belnacasan (USAN),
Belnacasan [USAN],
Belnacasan(VX-765),
(S)-1-((S)-2-(4-amino-3-chlorobenzamido)-3,3-dimethylbutanoyl)-N-((2R,3S)-2-ethoxy-5-oxotetrahydrofuran-3-yl)pyrrolidine-2-carboxamide,
851091-96-8,
00OLE78529,
N-(4-Amino-3-chlorobenzoyl)-3-methyl-L-valyl-N-[(2R,3S)-2-ethoxytetrahydro-5-oxo-3-furanyl]-L-prolinamide,
VX 765,
(2S)-1-[(2S)-2-[(4-amino-3-chlorobenzoyl)amino]-3,3-dimethylbutanoyl]-N-[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]pyrrolidine-2-carboxamide,
(2S)-1-[(2S)-2-[(4-amino-3-chlorophenyl)formamido]-3,3-dimethylbutanoyl]-N-[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]pyrrolidine-2-carboxamide,
Belnacasan [USAN:INN],
AK174935,
Belnacasan (VX765),
vx-765 (Belnacasan),
QCR-2,
C24H33ClN4O6,
GTPL9035,
SCHEMBL3393597,
CHEMBL2107819,
AOB87376,
ZINC3963010,
MFCD11100350,
s2228,
AKOS024464751,
SB19181,
NCGC00183682-10,
(s)-1-((s)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2r,3s)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide,
1-((2S)-2-((4-Amino-3-chlorobenzoyl)amino)-3,3-dimethylbutanoyl)-N-((2R,3S)-2- ethoxy-5-oxo-tetrahydrofuran-3-yl)-l-prolinamide,
1-(2-((1-(4-Amino-3-chlorophenyl)methanoyl)amino)-3,3-dimethylbutanoyl)pyrrolidine-2-carboxylic acid,
4CA-1340,
AS-35159,
L-Prolinamide, N-(4-amino-3-chlorobenzoyl)-3-methyl-l-valyl-N-((2R,3S)-2-ethoxytetrahydro-5-oxo-3-furanyl)-,
BCP0726000319,
AB0035843,
FT-0774330,
Y0257,
D10416,
Z-3198,
J-523035,
VX-765|||(2S)-1-[(2S)-2-[(4-Amino-3-chlorobenzoyl)amino]-3,3-dimethylbutanoyl]-N-[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]pyrrolidine-2-carboxamide,
VX765 cpd,
D0HK3N,
ARRY-520 HCl,
cc-448,
VRT-43198,
ACN-039814,
VRT-043198,
VX-765),
CID 9892498,
CID11398092,
Second generation ICE inhibitors, Vertex,
A8238,
A10984,
C520022,